1. Home
  2. RCUS vs DRD Comparison

RCUS vs DRD Comparison

Compare RCUS & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • DRD
  • Stock Information
  • Founded
  • RCUS 2015
  • DRD 1895
  • Country
  • RCUS United States
  • DRD South Africa
  • Employees
  • RCUS N/A
  • DRD N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • DRD Precious Metals
  • Sector
  • RCUS Health Care
  • DRD Basic Materials
  • Exchange
  • RCUS Nasdaq
  • DRD Nasdaq
  • Market Cap
  • RCUS 1.2B
  • DRD 1.2B
  • IPO Year
  • RCUS 2018
  • DRD N/A
  • Fundamental
  • Price
  • RCUS $8.17
  • DRD $14.82
  • Analyst Decision
  • RCUS Strong Buy
  • DRD Strong Buy
  • Analyst Count
  • RCUS 10
  • DRD 1
  • Target Price
  • RCUS $29.50
  • DRD $16.25
  • AVG Volume (30 Days)
  • RCUS 907.7K
  • DRD 587.3K
  • Earning Date
  • RCUS 05-07-2025
  • DRD 01-01-0001
  • Dividend Yield
  • RCUS N/A
  • DRD 1.60%
  • EPS Growth
  • RCUS N/A
  • DRD 28.24
  • EPS
  • RCUS N/A
  • DRD 1.05
  • Revenue
  • RCUS $258,000,000.00
  • DRD $374,318,123.00
  • Revenue This Year
  • RCUS N/A
  • DRD $21.38
  • Revenue Next Year
  • RCUS $28.07
  • DRD $5.29
  • P/E Ratio
  • RCUS N/A
  • DRD $13.81
  • Revenue Growth
  • RCUS 120.51
  • DRD 21.52
  • 52 Week Low
  • RCUS $8.02
  • DRD $7.64
  • 52 Week High
  • RCUS $18.98
  • DRD $15.25
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 30.17
  • DRD 66.46
  • Support Level
  • RCUS $8.02
  • DRD $13.88
  • Resistance Level
  • RCUS $9.19
  • DRD $14.55
  • Average True Range (ATR)
  • RCUS 0.46
  • DRD 0.55
  • MACD
  • RCUS 0.01
  • DRD -0.04
  • Stochastic Oscillator
  • RCUS 7.46
  • DRD 80.09

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields; and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

Share on Social Networks: